convey that, although the suggested course of action will be best for many patients, there will be some patients in whom, considering their comorbidities and/or their values and preferences, the alternative represents the best choice. The guideline will be updated as new evidence from comparative studies becomes available. A Patient Panel meeting was held prior to the Voting Panel meeting to gain insight into patients' values and preferences for the pharmacologic/nonpharmacologic intervention